1042634

アリピプラゾール

United States Pharmacopeia (USP) Reference Standard

• 別名: 7-{4-[4-(2,3-ジクロロフェニル)-1-ピペラジニル]ブトキシ}-3,4-ジヒドロ-2(1H)-キノリノン
• 実験式（ヒル表記法）: C₂₃H₂₇Cl₂N₃O₂
• CAS番号: 129722-12-9
• 分子量: 448.39
• MDL number: MFCD00892072
• UNSPSC Code: 41116107
• NACRES: NA.24

特性

• 製品名: アリピプラゾール, United States Pharmacopeia (USP) Reference Standard
• SMILES string: Clc1c(cccc1N2CCN(CC2)CCCCOc3cc4c(cc3)CCC(=O)N4)Cl
• InChI: 1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)
• InChI key: CEUORZQYGODEFX-UHFFFAOYSA-N
• grade: pharmaceutical primary standard
• API family: aripiprazole
• manufacturer/tradename: USP
• application(s): pharmaceutical (small molecule)
• format: neat

詳細

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Application

Aripiprazole USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Aripiprazole Orally Disintegrating Tablets
• Aripiprazole Tablets

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Other Notes

Sales restrictions may apply.

安全性情報

• pictograms: GHS07
• signalword: Warning
• hcodes: H302
• pcodes: P264 - P270 - P301 + P312 - P501
• Hazard Classifications: Acute Tox. 4 Oral
• 保管分類: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable